论文部分内容阅读
目的:分析比较对恶性梗阻性黄疸双介入法治疗的疗效。方法:本组65例恶性梗阻性黄疸患者,其中30例先行经皮肝穿刺胆管引流术(PTBD)/经皮肝穿刺胆管支架置入术(PTBS),待黄疸缓解后择期再行经皮动脉灌注化疗栓塞术(TACE)/单纯经皮动脉灌注化疗术(TAI),35例只行PTBD/PTBS,比较其生存期和生存率。结果:两组病人生存期、生存率有显著差异(P<0.01)。结论:恶性梗阻性黄疸采用双介入法治疗,在延长病人生存期,提高生命质量方面疗效显著。
Objective: To analyze and compare the efficacy of double interventional therapy for malignant obstructive jaundice. Methods: Totally 65 patients with malignant obstructive jaundice were treated with percutaneous transhepatic biliary drainage (PTBD) / percutaneous transhepatic biliary stenting (PTBS). Thirty patients underwent percutaneous transcatheter arterial perfusion Chemotherapy and embolization (TACE) / transcutaneous arterial infusion chemotherapy (TAI), 35 patients underwent only PTBD / PTBS, and compared their survival and survival rates. Results: There were significant differences in survival and survival between the two groups (P <0.01). Conclusion: The treatment of malignant obstructive jaundice by dual interventional therapy has significant curative effect in prolonging the survival of patients and improving the quality of life.